Technical Analysis for BHVN - Biohaven Pharmaceutical Holding Company Ltd.

Grade Last Price % Change Price Change
grade C 38.54 -0.28% -0.11
BHVN closed down 0.28 percent on Friday, August 23, 2019, on 51 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical BHVN trend table...

Date Alert Name Type % Chg
MACD Bullish Signal Line Cross Bullish -0.28%
Oversold Stochastic Weakness -0.28%
Spinning Top Other 2.99%
Oversold Stochastic Weakness 2.99%
NR7 Range Contraction 3.10%
Oversold Stochastic Weakness 3.10%
Shooting Star Candlestick Bearish 0.97%
180 Bearish Setup Bearish Swing Setup 0.97%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.97%
Oversold Stochastic Weakness 0.97%

Older signals for BHVN ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Biohaven Pharmaceutical Holding Company Ltd. is a United States-based biopharmaceutical company. The Company is engaged in the identification and development of clinical-stage compounds targeting orphan neurologic indications and other neurological pathways. It has a portfolio of multiple late-stage drug candidates. Its pipeline includes BHV-0223, which is a formulation of a glutamate-modulating agent; BHV-4157, which is a new chemical entity (NCE) that modulates glutamate, and BHV-5000, which is an in-licensed investigational agent of the Company targeting N-Methyl-D-Aspartate (NMDA) receptor antagonism. Its clinical compound, trigriluzole, is indicated for neurodegenerative diseases and cancer indications, among others. Its pipeline also includes BHV-3000 and BHV-3500, which are in-licensed by the Company for a neurologic indication. It focuses on advancing other mechanistic approaches in orphan and neuroscience indications, and is exploring licenses for additional compounds.
Biopharmaceutical Cancer Drugs Chemical Compounds Organic Compounds Neuroscience Neurodegenerative Diseases Riluzole
Is BHVN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 67.86
52 Week Low 29.17
Average Volume 1,144,861
200-Day Moving Average 45.701
50-Day Moving Average 42.4428
20-Day Moving Average 39.7275
10-Day Moving Average 38.139
Average True Range 1.9446
ADX 27.26
+DI 13.3265
-DI 18.4493
Chandelier Exit (Long, 3 ATRs ) 39.3862
Chandelier Exit (Short, 3 ATRs ) 42.7738
Upper Bollinger Band 43.9732
Lower Bollinger Band 35.4818
Percent B (%b) 0.36
BandWidth 21.374111
MACD Line -1.6993
MACD Signal Line -1.8651
MACD Histogram 0.1659
Fundamentals Value
Market Cap 1.38 Billion
Num Shares 35.8 Million
EPS -7.54
Price-to-Earnings (P/E) Ratio -5.11
Price-to-Sales 0.00
Price-to-Book 5.62
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 40.27
Resistance 3 (R3) 40.38 39.91 39.98
Resistance 2 (R2) 39.91 39.47 39.85 39.88
Resistance 1 (R1) 39.22 39.20 39.57 39.12 39.79
Pivot Point 38.76 38.76 38.93 38.70 38.76
Support 1 (S1) 38.07 38.32 38.42 37.96 37.29
Support 2 (S2) 37.61 38.05 37.55 37.20
Support 3 (S3) 36.92 37.61 37.10
Support 4 (S4) 36.81